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NUMEROUS attempts have been made to propagate human tumours in labora-
tory animals.
Woglom (1913) in a review on the study of experimental cancer, stated:
"Since the day when Peyrilhe made the first recorded experiment, attempts to
transfer cancer from man to the lower animals have been almost continuously
in progress, and although a positive result has been reported more than once the
consensus ofopinion has been for many years that such claims cannot be seriously
entertained."
Woglom relates how Peyrilhe in 1775 procured about two drachms ofcancerous
virus from a cancerous breast and introduced it into a small wound made in the
back of a dog. His maid, however, was "disgusted by the stench of the ulcer
and, softened by the cries of the animal, terminated the experiment by killing
the dog ".
Some of the early attempts at intracerebral inoculation of human cancer were
reviewed by Sailer (1900). He quotes Geissler (1891), who inoculated human
carcinoma into the brains of 25 rabbits and in those that were killed for study,
the fragments of carcinoma, although tolerably well preserved, exhibited no
tendencyto proliferate, andproducedexceedinglylittle reaction inthe surrounding
nervous tissue.
Sailer also refers to Trasbot who for "thirty years performed numerous experi-
ments, injecting carcinomatous substances and material into animals, with only
one successful tumour, which developed in the course of a few weeks at the site
of inoculation and then gradually atrophied".
In concluding his critical review Sailer said that "the transmission oftumours
to the lower animalsfrom human beings may be regarded as absolutelyimpossible,
unless someprofound modification intechnique orinthepreparation ofthe animals
subjected to the experiments shall be devised ".
Ehrlich (1907), quoted by Selbie (1936) demonstrated that a mouse tumour
could grow progressively in the rat for a period of 8 to 10 days, after which it
invariably regressed. By zig-zag transplantation between rat and mouse, Ehrlich
was able to cultivate a mouse tumour through fourteen passages.
Between 1913 and 1930 reports of the successful heteralogous transplantation
of animal tumours were published by Murphy (1913), Shirai (1921), Putnoky
(1930) and others.
Selbie (1936), after transplanting the Ehrlich-Putnoky mouse tumour
subcutaneously into rats, made detailed histological studies of the temporaryF. C. CHIESTERMAN
survival and proliferation of the tumours, and concluded that the transplanted
animals could in no sense be said to be suffering from cancer and that heterologous
transplantation was of little importance in the study of cancer.
Greene (1938), reported the slow but progressive growth of a human scirrhous
carcinoma ofthe breast for more than 80 days in the anterior chamber ofthe eyes
of7 out of 12 rabbits used. Growthwas first apparent towards the end ofthe third
week. Other papers by Greene (1941, 1942, 1946, 1948, 1949, 1951, 1952, 1953,
1954) described success in transferring animal and human tumours to the anterior
chamber of the eye and brain of alien species. Adult normal tissues, benign
tumours, hyperplasias, so-called pre-cancerous lesions and inflammatory gran-
lomas were incapable of growth after heterologous transfer, but some embryonic
tissues and cancers survived and grew.
No morphological criteria could be found to distinguish transplantable and
non-transplantable tumours. Histologically the transplants were usually identical
with the parent tumour.
Greene (1952) reviewed his results between February, 1939, and February,
1950, consisting of 127 transplantation experiments from 123 different patients,
and suggested that heterotransplantability differentiates phases of tumour
development rather than varieties oftumour, andthatnon-transplantable tumours
represent early developmental phases, and the transplantable tumours a later
stage.
Transplants were performed by Greene himself into one eye of 6 to 8 guinea-
pigs for each experiment. The following table, taken from his paper, shows the
relationship between the state ofthe patient at the time oftransfer and the results
oftransplantation (Table I).
TABLE I.-Relationship between State ofPatient and Results of
Transplantation (Greene).
No
involved Local Distant
nodes or nodes nodes Organ
metastases. involved. involved. metastases.
Number of cases . . . 45 . 41 . 9 . 28
Number of cases successfully trans-
planted . . . . 13 . 16 . 8 . 28
Percentage ofcases successfully trans-
planted . . . . . 28 8 . 39 0 . 88 8 . 100
Other workers have been less successful in their attempts.
Morris, McDonald and Mann (1950) made transplants of 40 malignant tumours
of human beings into the anterior chambers of 167 guinea-pigs, producing only 1
successful implant, and suggested that successful heterologous transplantation
of tumour tissue as a biological test of malignant disease was not a feasible pro-
cedure.
In 1951 Andrus, Meissner and Whorton transplanted 38 human malignant
tumours and 10 human lymphomas into the anterior chambers of the eyes of 383
guinea-pigs. Generally six to ten animals were used for each tumour. Twelve
transplants from 6 of the tumours showed unequivocal evidence of growth (3
melanocarcinomas, 2 bronchogenic carcinomas and 1 renal-cell carcinoma). In
4 of these cases metastatic tumour was used for transplantation. None of the 10
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lymphoma transplants showed evidence of growth. They concluded that in
their hands the low incidence of positive anterior chamber transplants definitely
limits the value of the procedure as a diagnostic test.
Greene (1951) reported the successful growth of human cancer in the guinea-
pig and mouse brain; the majority of the mice died between the 70th and 90th
days. He concluded that the rapidity with which human cancergrewinthe mouse
brain together with the low cost of mice were factors ofimportance in the clinical
use of heterotransplantability as a prognostic test. It was found that with the
exception of brain neoplasms, "only metastasizible tumours were heterotrans-
plantable, and this fact was utilizedto determine the status ofhumantumours with
respect to metastasizability at the time of their removal ".
It was suggested that the mouse brain could be used in place ofthe guinea-pig's
eye with advantage from the standpoint of both time and economy.
Eichwald, Goodman and Chang (1951) found that tumours of mouse sarcoma
37 grew to a larger size without regression in the sub-dural space of guinea pigs
than in similar transplants to the guinea-pig eye.
Green and Whiteley (1952) showed that cortisone strongly depressed antibody
production to iso-antigens, and heterologous antigens in transplanted tumour
tissue. They described the absence of cellular reaction at 6 to 16 days around
human "oat-cell" carcinoma transplanted subcutaneously in 5 mice receiving
cortisone. The implants showed evidence of non-invasive tumour growth at the
periphery. There was a very considerable reaction around the implant in the
control mice. Toolan (1953) reported success in transplanting human tumours
subcutaneously into cortisone-treated X-irradiated weanling rats.
This investigation was undertaken to confirm the fact that human tumours
could be grown within the skull of the mouse, and to explore the possibilities of
this method as a biological test for malignancy. It was hoped to increase the
number of "takes" by conditioning the host with cortisone.
This paper is a report on the results of the intracranial implantation into 180
mice of preparations of 20 human malignant tumours from 19 patients.
METHODS AND MATERIAL.
White mice of both sexes, inbred but not of a pure strain, between 30 and 161
days old at the time of implantation were used. They were fed on a standard
cube diet. Intraperitoneal avertin (approximately 0.1 ml. of a 2-5 per cent
solution per 10 g. bodyweight) was used as an anaesthetic. Thisgave satisfactory
deep anaesthesia for 20 minutes or longer, and the animals were sleepy for some
hours after the operation.
Under anaesthesia the skin over the head was shaved with a scalpel blade.
No antiseptic was put on the skin, but sterile instruments were used.
Three methods for introducing the tumour material into the brain were used,
depending on the nature of the material available.
(1) A right paramedian saggital incision down to the bone was made and the
skull then drilled with a modified dental drill 1 mm. in diameter and projecting
about 2 mm. from inside a small metal cylinder which acted as a guard when the
skull had been penetrated.
This method was used when small pieces of solid tumour about 11 mm. in
size were directly implanted into the brain after puncturing the dura. The tissues
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were pushed into the brain with a fine pair offorceps or from a modified Bashford
needle used for implanting tissue as described below.
(2) In some instances scrapings from the cut surface ofthe tumour were drawn
into a modified Bashford needle consisting of a closely-fitting stilette projecting
2 mm. beyond a short-bevelled needle mounted on a handle. In tumours of
suitable consistency it was possible to use the stilette as a plunger and suck
material directly into the needle. The needle was then inserted into the brain
through the intact skull, the stilette was depressed and the tumour material
deposited intracranially. The skin incision was closed with one small Michel
clip.
(3) If the tumour was sufficiently fluid (e.g. in centrifuged suspensions of
pleural fluid or bone marrow) the material was drawn into a Mantoux syringe and
approximately 0.025 ml. inoculated through a No. 16 or 18 guage needle.
Some of the mice received one post-operative injection of a suspension con-
taining 3000 units of procaine with penicillin G and 1000 units of sodium peni-
cillin G. 1.25 mg. cortisone acetate was given subcutaneously daily to some ofthe
mice 1 to 3 days before operation and continued daily for the first few days.
Subsequently the dose was reduced as signs ofintolerance developed.
Bacteriological culture was not performed on the implanted tissue, but intra-
cerebral abscesses were only occasionally found.
The material used was received from the operating theatres of the Middlesex
Hospital, the Soho Hospital for Women and the Harefield Hospital for Diseases
of the Chest. Autopsy material was obtained from the Bland Sutton Institute
of Pathology. Portions of tissue adjacent to those implanted were sectioned, or
smears made from scrapings and centrifuged deposits.
Material was implanted into the mice within 3 hours ofreceipt from the theatre.
Naturally during the operative procedures in removing various tissues from
the patient some of the cells may have been deprived of their blood supply for
longerperiods. In the case ofpost-mortem material delaywas up to 12 hours from
death.
Animals that had not died were killed at various times up to 300 days after
implantation. As soon as possible after death the skin over the dorsum of the
skull was removed and the skull and brain cut through with a sharp scalpel in
the region of the burr-hole, or the fracture made by the Bashford needle. The
heads were fixed in formal-saline, decalcified, and sections cut in the region ofthe
implanted area. In cases where intracerebral inoculation was performed with a
Mantoux syringe, sections of the brain were made in the region of the inoculated
area.
DEFINITION OF A TAKE
When interpreting the results of intracranial transplantation it is essential
to define what is meant by a "take" or a "positive result ".
The mere survival of cells which appear viable using standard histological
criteria must be distinguished from growth where, as a result of reproduction,
there is an increase in the total number of transplanted tumour cells with apro-
gressive infiltrating or expanding tumour showing numerous mitoses.
Lumb (1954a, 1954b) reporting on the results of the transplantation of 60
human tumours into mouse brains, made serial sections to demonstrate the histo-
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logical appearances of the implanted tissue up to 28 days and in 3 cases up to 35
days. Isolated clumps of cells sharply demarcated from adjacent brain and
appearing "viable" using normal methods of histology were seen in 40 cases.
He stated: "It is obvious that if a transplanted tumour grew as a solid mass
to destroy a considerable area of host tissue then no doubt would remain that
frank growth was taking place in the transplanted area." He found no such
growth and only in 2 cases was there evidence of infiltration by tumour cells at
the edge of the inoculation area.
It is evident that even after 35 days the presence of apparently viable cells
is no criteria of growth; local invasion is very suggestive, but it seems likely
that only increase in size due to an increase in the total number of tumour cells
is absolute proof of growth.
Kemler and Graham (1950) studying the influence of sex hormones on success-
ful heterologous transplants of human bronchogenic carcinoma in the anterior
chamber of guinea-pig eyes defined a "take" as at least a twofold enlargement
of the transplant with definite vascularization. They used fragments of tumour
tissue, 1 to 2 mm. in size and obtained growth in 6 of 29 attempted transfers in
female guinea-pigs and 4 out of 29 in males.
Towbin (1951) evaluated the results of 100 different malignant human tumours
transplanted into the anterior chamber of the guinea-pig's eye and described
three phases in the tumour development.
(1) Suspension stage, in which the transplant exists in a "tissue culture"
state, deriving nourishment from the surrounding medium.
(2) Nidation stage, during which the transplant becomes attached and
vascularized.
(3) Growth stage, during which active proliferation of the tumour elements
is manifested.
Ofthe 100 different malignant human tumours studied by Towbin, 89 tumours
showed early regression oftransplanted tissue; 9 tumours persisted in the stage of
nidation for 10 to 114 days, and only 2 tumours (a fibrosarcoma and a carcinoma
of the maxillary sinus) showed active growth after long latent periods in the
anterior chamber.
The results indicated that relatively few human tumours, though clinically
malignant, could be transplanted successfully to the anterior chamber of the
guinea-pig's eye andthatthisfactorprecluded the use ofthetechnique as apractical
measure for differentiating benign from malignant tumours.
RESULTS.
Of the 20 human tumours in this series only 3 (from Patients F, J and C with
lung cancer) showed evidence of infiltrative or expansive growth in a few of the
mice implanted. In these instances, which have been reported briefly previously
(Chesterman, 1953), the type of growth within the mouse skull was classified as
follows:
Macorscopic tumours: Two tumours (Cases F and J) were placed in this group
(Fig. 3, 4, 5, 6, 8). They formed expanding growths after a period of 60 days
in the host, easily visible to the. naked eye on section of the skull, and about
half the diameter of the mouse's brain when seen on cross section. They grew
as a solid mass compressing the host tissue. On histological examination they
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were vascularized, organized and showed numerous mitoses. In general, they
were sharply demarcated from the surrounding brain, but in places showed
infiltration.
Microscopic tumours: This term was applied to transplants of over 12 days'
duration, not clearly seen by the naked eye, but showing on section unequivocal
evidence of invasion of the host tissue or, as seen in one mouse, of the stroma
surrounding malignant cells in the implant. Four mice were placed in this
group, two in Case F, one in Case J, and one in Case C.
The presence of cells appearing "viable" on the usual histological criteria
was found in the brains of two cortisone-treated mice dying at 7 and 10 days
bearing implants from two human malignant melanomata. Six and 12 mice were
originally implanted.
"Viable" cells were also seen in one cortisone-treated mouse dying at 7 days
and bearing an implant from a mixed squamous and adenocarcinoma arising
in an ovarian dermoid cyst (15 mice originally implanted) (Fig. 11 to 15).
EXPLANATION OF PLATES.
FIG. 1.-Coronal section of head of normal mouse. x 31.
FIG. 2.-Histological preparation of a coronal section of a normal mouse's head. H. & E.
x 3j.
FIG. 3.-Case F. Coronal section of head of mouse showing a "macroscopic tumour" in the
middle of the brain at 128 days. x 5.
FIG. 4.-Case F. Low power microphotograph of "macroscopic tumour" in the brain at 128
days. H. & E. x 7.
FIG. 5.-Case J. "Macroscopic tumour" at 66 days showing vascularized tumour expand-
ing overlying skull. H. & E. X 8.
FIG. 6.-Case J. High power of tumour shown in Fig. 5. H. & E. x 640.
FIG. 7.-Case J. Section of original subcutaneous deposit of secondary carcinoma used for
transplantation. H. & E. x 640.
FIG. 8.-Case J. Coronal section of head of mouse showing appearance of "macroscopic
tumour" at 66 days. Largest diameter of tumour 5-5 mm.
FIG. 9.-Case F. Section of edge of tumour at 128 days showing blood vessel. H. & E.
x 320.
FIG. 10.-Case C. Microscopic growth at 56 days in the brain of a cortisone-treated mouse
adjacent to a portion of "viable" bone pushed into the brain during the operation.
H. &E. x 340.
FIG. 11, 12 and 14.-Sections showing areas of squamous cell carcinoma and adenocarcinoma
in the original malignant ovarian dermoid cyst. H. & E. x 320.
FIG. 13 and 15 show a few isolated clumps ofcells and some stroma in the brain ofa cortisone-
treated mouse dying 7 days after implanatation with material from the ovarian tumour
shown in Fig. 11, 12 and 14. H. & E. x 320.
FIG. 16.-Case J. Vascularized tumour 43 days after implantation growing in ventricle and
adjacent brain (cortisone-treated mouse). H. & E. x 35.
FIG. 17.-High power of Fig. 16 showing growth replacing ependymal lining and invading
brain. Numerous mitoses. H. & E. x 185.
FIG. 18.-Case F. "Microscopic growth" at 13 days in lateral ventricle and choroid plexus
from intracerebral inoculation of scrapings from the cut surface of the tumour. H. & E.
x 35.
FIG. 19.-Case F. High power of Fig. 18, showing invasion of the brain substance. H. & E.
x 185.
FIG. 20.-Implanted tissue from case of carcinoma of the breast in a cortisone-treated mouse
dying at 6 days, showing no cellular reaction to the implant which contains no malignant
cells in the portion sectioned. H. & E. x 32.
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No growth was demonstrable in mice dying or killed subsequently in these
cases or from the remaining 14 human tumours, where only 6 mice (3 on cortisone)
were used. These may be classified as follows:
Group 1.-Primary tumour used for implantation. No demonstrable lymph
node or organ metastases. (Squamous cell carcinoma of the lung. Seminoma
of the testis. Carcinoma of the breast.).
Group 2.-Primary tumour used for implantation. Histological confirmation
of invaded regional lymph nodes. No demonstrable organ metastases. (Three
cases of carcinoma of the breast. One polygonal-cell carcinoma of the lung.)
Group 3.-Tumour from regional nodes implanted. No demonstrable organ
metastases. (Carcinoma of breast. Carcinoma ofnaso-pharynx.)
Group 4.-Organ metastases implanted. (Squamous cell carcinoma of lung
with liver metastases (surgical biopsy.) Lymphosarcoma in a child of 7. (Post-
mortem material from liver.)
Group 5.-Centrifuged deposits from the following:
(1) Pleural fluid containing malignant cells in a case of squamous
cell carcinoma of the cervix, proven at autopsy. (12 mice inoculated;
6 on cortisone.)
(2) Sternal marrow obtained after death from a case ofacute leukaemia
(monocytic type Naegli.)
(3) Sternal marrow from a case of Hodgkin's Disease.
Details ofthe three successful cases in which larger numbers ofmice were used
for implantation follow:
Case F.-Male, aged 50. Admitted to Harefield Hospital on September 17,
1952 with a history oflassitude since June, 1952. Signs ofcollapseoftheleftupper
lobe with overlying pleurisy were present. Bronchoscopy revealed a mass of
tissue blocking the left upper lobe orifice. Biopsy showed "oat cell" carcinoma.
Radiotherapy was given as the growth was inoperable. Bronchoscopy on Decem-
ber 31, 1952, revealed no sign of the tumour and biopsy showed a few degenerate
cells only. Patient returned in April, 1953, with six subcutaneous nodules, the
largest of these was removed under local anaesthesia and revealed "oat cell"
carcinoma.
Portions of this tumour were used for implantation. Patient died May 17,
1954, with generalised secondaries. No autopsy performed, but there were signs
of secondary deposits in the brain.
Case C.-Male, aged 52. Admitted to Harefield Hospital under the care of
Mr. T. Holmes Sellors with 7 weeks' history of pains in the chest and haemoptysis.
X-ray revealed a mass in the left lower lobe apical section, and on September 3,
1953, a left pneumonectomy was performed. Recovery was uneventful, but on
October 2, 1953, patient was re-admitted with secondary deposits and died
on December 12, 1953.
The specimen consisted of a large peripheral type growth in the left lower
lobe (apical section). Growth had spread to the broncho-pulmonary glands,
but although the hilar glands were free, removal was probably incomplete, due to
invasion of the pleura. Histology showed an "oat cell" carcinoma with tubule
formation and extensive squamous metaplasia.
Case J.-Male, aged 56. Admitted to Edgware General Hospital June, 1953,
under the care of Dr. G. S. C. Sowry with an opacity in the right lung. Biopsy
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showed an " oat cell" carcinoma. His condition improved on radio-therapy,
but in October, 1953, he was admitted to the Middlesex Hospital with deposits in
the spine and numerous subcutaneous nodules over the chest and abdomen.
One of these was removed under local anaesthesia and used for implantation (Fig.
7). The patient died 4 days later. Permission for a post-mortem was refused.
The results of tumour transplantation in these three cases are conveniently
summarized in Table II.
TABLE II.-Results of Tumour Transplantation.
Number Number
Number of mice of mice
Number surviving showing showing
of mice after "microscopic "macroscopic
implanted. 7 days. tumours." tumours."
Case F.
Cortisone treated . 9 . 6 . 2 (13 & 26) . 0
No cortisone . . . 12 10 0 . 1 (128)
Case C.
Cortisone treated . 6 . 5 . 1 (56) . 0
No cortisone . . . 6 . 5 . 0 . 0
Case J.
Cortisone treated . . 12 . 12 . 1 (43) . 0
No cortisone . . 12 10 . 0 . 1 (66)
The figures in brackets refer to the number of days at which growth was observed.
HISTOLOGY.
Site ofgrowth.
Growing tumour was found in the brain substance, in the ventricles, in the
choroid plexus and in one cortisone-treated mouse in the stroma of the donor
tissue when the implant was not wholly within the brain substance.
Murphy and Sturm (1923), discussing conditions determining the transplanta-
bility oftissues in the brain, and working with mouse tumours transplanted to the
brain of rats, guinea-pigs and pigeons, found that the growth of foreign tissue in
the brain took place only when the grafted material lay entirely in the brain
substance, but when it came in contact with the ventricle a cellular reaction
took place with resultant destruction of the graft.
Fig. 16 and 17: Case J shows vascularized invasive growth at 43 days in a
cortisone-treated mouse replacing the ependymal lining.of the lateral ventricle
with no surrounding cellular response.
Fig. 18 and 19: Case F shows growth invading the brain substance from the
ventricle of a cortisone-treated mouse dying at 13 days after inoculation of scrap-
ings from the cut surface of the donor tumour.
No metastases were observed at post-mortem or on histological examination
of liver, lungs, and kidneys of the mice where intracranial growth was observed.
Intracranial transfer of portions of the macroscopic tumours to other mice was
unsuccessful. There was a delay of some hours before transfer, as both mice
died from the intracranial tumours.
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Type ofgrowth, cellular reaction and vascular supply.
In 1912 DaFano investigated homologous intracerebral transplantation of
animal malignant tumours and found that growth was infiltrative or expansive,
or a combination of both. The stroma originated from the blood supply of the
brain and a reaction of plasma cells and lymphocytes appeared only in partially
immune animals.
In the present investigation infiltrative and expansive growth was found, and
the morphology ofthe cells resembled that of the original biopsy.
Although numerous thin-walled blood vessels could be seen in the tumours
it is not obvious if these were provided by the host or grew from the implanted
tissue. The macroscopic tumour of Case J (Fig. 5 and 6) was surrounded by an
area containing blood. Numerous thin-walled vessels in the tumour opened
into this pool of blood, but no direct continuity of cerebral and tumour vessels
could be seen.
In the macroscopic tumour of Case F there was no surrounding pool of blood,
but there were numerous vessels in the tumour and at the periphery adjacent
to the brain substance (Fig. 9). The centre of this tumour was undergoing
necrosis when the mouse died on the 128th day after implantation.
Vessels were seen in the growths at 56 days (Case C) and 43 days (Case J).
There was no cellular reaction around the macroscopic or the microscopic
tumours at 56 days (Case C) and 43 days (CaseJ). At 26 days (Case F) there was a
mild reaction round the graft of mononuclear cells, lymphocytes, microglial and
gitter cells, and occasional plasma cells.
This cellular reaction was not as marked as that seen around some of the
implanted tissue from cases of breast cancer and in two mice dying on the 11th
day (Case F) where cortisone was not started until 5 days after implantation.
Portions ofmouse hair and fragments ofskull bone implanted with the tumour
were sometimes observed (Fig. 10).
DISCUSSION
One of the major difficulties of intracranial transplantation is in the choice of
suitable material from the tissues submitted.
Franks (1953) transplanting animal tumours to the guinea-pig eye found that
with solid tumour transplants there was almost always central necrosis and a
very severe inflammatory reaction with a polymorphonuclear exudate. With
cell suspensions or ascites tumour cells the initial inflammatory reaction was much
less marked.
Greene (1953) reporting the successful heterologous transplantation ofthirteen
cases oflung cancer stated: "The point to be emphasized is that the incidence of
'takes' in the first-generation passage ofa heterologous tumour reflects its content
of desmoplasia and the experience of the operator rather than any essential
character of the neoplastic cells. From this point of view a single 'take' is as
expressive ofthe true nature ofthe tumour as a 100 per cent incidence and unless
a complete uniformity of transplanted fragments with respect to desmoplasia and
parenchyma is assured, a tabulation of the incidence of 'takes' is not subject to
meaningful interpretation."
In the present series growth has been obtained by using each ofthe techniques
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outlined previously, but the original tumours in each case contained a large
proportion of malignant cells relative to the supporting stroma.
The result in tumours containing more stroma can be illustrated in a case of
carcinoma of the breast, where the fragments of tissue adjacent to those used for
implantation showed roughly equal proportions of stromal and parenchymatous
areas. One ofthe mice dying at 6 days showed the implanted material to consist
of a mass of stromal fibrous tissue with no tumour cells in the portion sectioned
(Fig. 20). Supporting tissue appeared to survive in the brain for a considerable
number of days after implantation.
Some ofthe failures may be due to the fact that frozen sections were not done
to assist in the choice of suitable material for implantation. In addition it was
not always possible to locate the original implanted tissue or scrapings, and serial
sections were not employed when nothing was seen in the operation area.
The survival rate of the mice was also a limiting factor. Only a few died
during the operation, and these were replaced if enough tumour material was
available. Some mice had to be killed or died in the first 14 days after implanta-
tion from trauma, haemorrhage, infection orhydrocephalus. After this somewhat
stormy convalescence, no grossneurological signs were noticed except in one mouse
(Case J), which showed paralysis of the left hind leg on the 59th day after intra-
cerebral tumour inoculation. This mouse died 7 days later from the effect of the
"human" tumour growing and compressing the brain and distending the skull.
Although it appears from the table that there is an increased incidence of
microscopic growth in the cortisone-treated animals, the number of surviving
animals was too small to assess the effects of the hormone on the growth of the
implant or the cellular response of the host.
Material from cases of lung cancer appears to grow more readily than other
tumours.
This has been the finding ofGreene (1953), who postulates that human tumours
which can be grown in animals are autonomous, whilst those which do not grow
are in a dependent phase. The explanation may however be related to the host
tissue rather than the tumour, and it is interesting that lung tumours have a
peculiar tendency to metastasize to the brain.
In the three successful growths reported here, Case F died within 2 years of
first admission to hospital, and Cases C and J within 6 months.
Case F and Case J had received radiotherapy before the appearance of the
secondary subcutaneous nodules used for animal implantation.
To summarize, it is apparent that in view of the results obtained in these
experiments and in those of other workers, heterologous transplantation using
techniques at present available, does not appear to be a practical routine test
for the biological activity of any given tumour, but it may provide a method for
propagating certain human tumours in laboratory animals for experimental
purposes.
SUMMARY.
Material from 20 human tumours has been implanted intracranially into a
series of 180 mice.
No growth of the implanted tissue could be demonstrated in 17 of the 20
groups of mice.
In the remaining 3 cases of metastatic "oat cell" carcinoma of the lung infil-
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trating growth was obtained between 13 and 128 days in 6 of the mice implanted.
One mouse each from 2 of these cases died 66 and 128 days after implantation
from the effects of a large expanding intracranial vascu]arized "human" tumour.
On section these occupied about half the width of the normal mouse skull and on
microscopy showed malignant cells with numerous mitoses resembling the original
biopsy.
Some of the animals were treated with cortisone in an attempt to increase the
number ofsuccessful implants; but there is insufficient data on the small number
of animals surviving to assess the effects of the hormone. Growth was obtained
in animals treated with cortisone as well as in normal animals.
Part of the expenses of this investigation has been defrayed by the British
Empire Cancer Campaign. Cortisone was received from the Medical Research
Council and from Messrs. Merck and Company, Rahway, New Jersey, U.S.A.
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Franks for placing at my disposal his modification of the Bashford needle; to
Mr. E. V. Willmott, F.R.P.S. for some of the photographs, and to Mr. H. A.
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